Insider selling
Traded Nov 17 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade −1.3% · S&P 500 −5.8% · to Nov 20
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
CON · NYSE · Health Care Services
Concentra Group Holdings Parent, Inc. (CON) · oqro.io/stocks/CON · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$41.84+0.39 (+0.94%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
No open-market purchase by an insider of Concentra Group Holdings Parent, Inc. is on record in SEC filings since 2006.
Since 2026, Concentra Group Holdings Parent, Inc. insiders reported 0 open-market purchases and 10 sales on Forms 4 and 5.
In the last 90 days, 6 insiders of Concentra Group Holdings Parent, Inc. (CON) reported 6 open-market sales worth $6.16M in total on SEC Form 4. The largest seller by value was William Keith Newton, with $2.94M. Many insider sales follow a plan set in advance or cover taxes on stock awards; the filing says what was sold, not the reason.
No trade in Concentra Group Holdings Parent, Inc. (CON) was disclosed by a member of Congress in the last 12 months.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
+115.0% (+$22.38) from Nov 20, 2025 to Nov 20, 2026 · adjusted daily closes
Adjusted close went from $19.46 on Nov 20, 2025 to $41.84 on Nov 20, 2026 (+115.0%). Disclosed in this range: 6 insider trades, 4 pre-arranged insider sales, 0 Congress trades, and 1 13F position change for 1 quarter ending in it.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Health Care Services company based in Mechanicsburg, Pennsylvania.
Last 12 months
+115.0%
Market value
$5.29B
S&P 500 +5.7% over the same dates. Prices adjusted for splits and dividends.
Short interest: 2.27M shares sold short (1.8% of shares outstanding), −37.0% vs the previous count, 1.9 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.
Revenue
$622M
+8.6% vs the same quarter a year earlier
Free cash flow, last 12 months
$257M
This quarter $29.4M, a year earlier $39.4M
Net debt
$1.42B
Debt $1.51B, cash $85.8M, at Sep 30, 2026
Net income, last 12 months
$216M
Operating profit covers interest 3.06x (latest fiscal year)
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Nov 5, 2026.
Revenue, fiscal 2025
$2.16B
+13.9% vs the year before
Net income, fiscal 2025
$166M
As reported in the annual filing
Shares outstanding
127M
As of Oct 31, 2026
In fiscal 2025 the company spent $22.4M buying back its own shares and $32.1M on dividends. Cash actually paid, from its cash-flow statement.
Last dividend: $0.0625 a share (quarterly), ex-date Nov 19, 2026, payable Dec 4, 2026. Calendar
Insider selling
Traded Nov 17 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade −1.3% · S&P 500 −5.8% · to Nov 20
Concentra Group Holdings Parent's See Remarks sold $748K of Concentra Group Holdings Parent shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Nov 17 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade −1.3% · S&P 500 −5.8% · to Nov 20
The CFO of Concentra Group Holdings Parent sold $122K of Concentra Group Holdings Parent shares. The filing does not indicate a pre-arranged trading plan.
John A. deLorimier (Officer) plans to sell ~$742K of Concentra Group Holdings Parent, Inc.
Planned, from payNewton Raymond Tanner (Officer) plans to sell ~$122K of Concentra Group Holdings Parent, Inc.
Planned, from payInsider selling
Traded Nov 16 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade −3.7% · S&P 500 −6.8% · to Nov 20
A Concentra Group Holdings Parent director sold $2.94M of Concentra Group Holdings Parent shares. The filing does not indicate a pre-arranged trading plan.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Against the S&P 500 over the year
Since Nov 19, 2025, CON is up 117.6% and the index fund is up 4.1%: 113 points ahead of the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much CON moves
Beta 0.5 (1 year vs SPY)
End-of-day prices. These figures describe the past year and say nothing about what comes next. Beta: how much the stock moved, on average, for each 1% move of the S&P 500 fund over 251 trading days (1 = in step with it).
Insiders of Concentra Group Holdings Parent, Inc. reported 0 open-market purchases and 10 sales since 2026; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $20.8M10×10 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Top officer leaving
“Newton’s transition from Chief Executive Officer (i) is not a termination of employment or service for purposes of his outstanding equity awards and (ii) does not constitute “Good Reason” under the K.”
8-K on sec.govTop officer leaving
“On August 4, 2026, Keith Newton, Chief Executive Officer of the Company and member of the Company’s Board of Directors (the “Board”), notified the Board of his intent to resign from the role of Chief Executive Officer, effective November 1, 2026, and transition to Executive Chairman of the Board.”
1 insider sold ~$8.1M in the 60 days before
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
Source: SEC Schedules 13D and 13G, which anyone owning more than 5% of a class of stock must file. A 13D filer may seek to influence the company; a 13G filer is passive. Filings before December 2024 are free text and read from their cover page: a percent or share count that is not stated plainly is left blank. Each line links to the filing.
Written by OQRO's software from the last 12 months on record · Nov 19, 2026
Every number, name, date and link in the text above comes from this list; software checks that before the text is stored. This text was assembled directly from the facts, without a language model.
Insiders
Congress
Funds and stakes
Contracts, lobbying and filings
Company reports, price and press
Who holds it
Things to keep in mind
Records
Latest annual report filed Feb 26, 2026, compared with the one filed Mar 3, 2025. Read the filing
Refer to the “Litigation” section contained within Note 18—“Commitments and Contingencies” of the notes to our consolidated financial statements included herein.
The company describes its cases in the notes to its financial statements, in the same filing.
Source: SEC EDGAR, Form 10-K filed Feb 26, 2026. Headings are the titles the company gives each risk; OQRO compares them with the year before by their words, so a heading that was reworded a lot shows up as both new and no longer listed. Companies list the risks they face, not forecasts.
The three months Jul 1, 2026 to Sep 30, 2026, compared with the same quarter a year earlier, from the quarterly report filed Nov 5, 2026. Quarterly reports are not audited. Read the filing
+8.3% on the same quarter a year earlier ($526M)
+10% on the same quarter a year earlier ($34.9M)
+18% on the same quarter a year earlier ($11.9M)
The company also reports Reportable Segment ($622M), which group lines above and are not added again.
Fiscal year Jan 1, 2025 to Dec 31, 2025, from the annual report filed Feb 26, 2026. Read the filing
+12% on the year before ($1.79B)
+72% on the year before ($64.1M)
+8.7% on the year before ($43.7M)
The company also reports Reportable Segment ($2.16B), which group lines above and are not added again.
Every annual report has a section where the company's managers explain the year's results (Item 7, Management's discussion and analysis). In this report it runs to about 9,000 words.
We were founded in 1979 and have grown to be the largest provider of occupational health services in the United States by number of locations. Our national presence enables us to provide access to high-quality care that supports our mission to improve the health of America’s workforce. As of December 31, 2025, we operated 628 stand-alone occupational health centers in 41 states and 411 onsite health clinics at employer worksites in 44 states. We also have expanded our reach via our telemedicine program serving 43 states and the District of Columbia. In total, we deliver services across 47 states and the District of Columbia.
And 25 more headings in the filing.
Source: SEC EDGAR, Form 10-K filed Feb 26, 2026 and Form 10-Q filed Nov 5, 2026. Revenue lines are the figures the company tags in its filing; OQRO shows a split only when its lines add up to the reported total revenue. The quote is the opening of the managers' discussion, cut at a sentence; the word count is estimated from its length. Not investment advice.
Off-exchange trading: 41.6% of the shares traded over the latest 4 published weeks changed hands away from the exchanges (26.1% on ATS, 15.5% with other brokers), close to its 26-week average of 39.7%. Weeks of Sep 21 to Oct 16, 2026.
Largest ATS: INTELLIGENT CROSS LLC (13.7%), UBS ATS (12.0%), MS TRAJECTORY CROSS (ATS-1) (10.1%), as a share of this stock's ATS volume over the same 4 weeks.
An ATS, often called a dark pool, is a private trading venue run by a broker where orders are not shown publicly before they trade. Other off-exchange trades are mostly retail orders filled by wholesale brokers. A high share is common and says nothing by itself about where the price goes. FINRA OTC Transparency data, published 2 weeks after each week for the largest stocks and 4 weeks for others; total volume from our daily price data.